PUBLICATIONS · 37306107
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer Med
- Publication date
- 2023 Jul
- First author
- Shulman DS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Shulman DS
- type
- Author
- name
- Merriam P
- type
- Author
- name
- Choy E
- type
- Author
- name
- Guenther LM
- type
- Author
- name
- Cavanaugh KL
- type
- Author
- name
- Kao PC
- type
- Author
- name
- Posner A
- type
- Author
- name
- Bhushan K
- type
- Author
- name
- Fairchild G
- type
- Author
- name
- Barker E
- type
- Author
- name
- Klega K
- type
- Author
- name
- Stegmaier K
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Shulman DS
- type
- Author
- name
- Merriam P
- type
- Author
- name
- Choy E
- type
- Author
- name
- Guenther LM
- type
- Author
- name
- Cavanaugh KL
- type
- Author
- name
- Kao PC
- type
- Author
- name
- Posner A
- type
- Author
- name
- Bhushan K
- type
- Author
- name
- Fairchild G
- type
- Author
- name
- Barker E
- type
- Author
- name
- Klega K
- type
- Author
- name
- Stegmaier K
- type
- Author
- bibliography ids
- nci-bib-7372bd2eb1e18bc4d84043cf
- book metadata
- content sha256
- bf21c0f5048d13a32e1d77ca7c4ede101be7d0428a5f74a8ec130c6fb1c86a04
- document type
- citation
- dois
- 10.1002/cam4.6208
- electronic publication date
- display
- 2023 Jun 12
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:37306107
- immutable id
- pubmed:37306107@bf21c0f5048d13a32e1d77ca7c4ede101be7d0428a5f74a8ec130c6fb1c86a04
- journal
- abbreviation
- Cancer Med
- issn electronic
- 2045-7634
- issn print
- Source null
- issue
- 14
- name
- Cancer medicine
- nlm unique id
- 101595310
- pages
- 15207-15216
- volume
- 12
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 37306107
- provenance
- batch id
- 5329a5d0877ee70ecd11
- provider
- NCBI PubMed ESummary
- record sha256
- aa60cde004258cf593b1b2fcf3a59d90cb45f9f5905c343b0b2f23b6c31d2690
- response sha256
- bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
- retrieved at
- 2026-09-09T23:48:15.763286+00:00
- publication date
- display
- 2023 Jul
- precision
- month
- year
- 2023
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.
Preserved source evidence · Not medical advice
Triangle